Aggarwal Gaurav insider trades
Aggarwal Gaurav has filed 14 Form 4s with the SEC that we hold, for Unicycive Therapeutics, Inc. (UNCY) (Director), Geron Corp (GERN) (Director) and SRRA (Director). Across all of them we count 1 purchase worth $21.6M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 800,000 shares of SRRA worth $21.6M, dated 2022-01-31. The first filing on our record is dated 2022-01-28 and the latest 2025-08-26.
Unicycive Therapeutics, Inc. (UNCY)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Geron Corp (GERN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SRRA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-31 | P, purchase reported on Form 4 | 800,000 | $21.6M | 2022-01-31 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1551965) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms